Market Closed -
Nyse
04:00:02 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
24.87
USD
|
+2.30%
|
|
+1.43%
|
-10.31%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,162
|
1,037
|
1,113
|
1,083
|
1,610
|
1,450
|
-
|
-
|
Enterprise Value (EV)
1 |
1,754
|
1,710
|
1,830
|
1,938
|
2,386
|
2,217
|
2,208
|
2,207
|
P/E ratio
|
13.6
x
|
57.1
x
|
8.31
x
|
10.3
x
|
16
x
|
13.2
x
|
11.1
x
|
-
|
Yield
|
4.15%
|
1.17%
|
0.11%
|
0.45%
|
-
|
0.34%
|
0.38%
|
0.41%
|
Capitalization / Revenue
|
0.79
x
|
0.91
x
|
0.72
x
|
0.53
x
|
0.85
x
|
0.73
x
|
0.69
x
|
0.64
x
|
EV / Revenue
|
1.19
x
|
1.51
x
|
1.18
x
|
0.95
x
|
1.26
x
|
1.11
x
|
1.05
x
|
0.98
x
|
EV / EBITDA
|
6.56
x
|
8.55
x
|
6.83
x
|
6.21
x
|
7.18
x
|
6.39
x
|
5.79
x
|
5.41
x
|
EV / FCF
|
23.2
x
|
-87
x
|
-26.3
x
|
-12.8
x
|
13.8
x
|
82.1
x
|
48
x
|
38
x
|
FCF Yield
|
4.31%
|
-1.15%
|
-3.8%
|
-7.84%
|
7.25%
|
1.22%
|
2.08%
|
2.63%
|
Price to Book
|
6.25
x
|
5.73
x
|
3.48
x
|
2.35
x
|
3.36
x
|
2.66
x
|
2.26
x
|
2.02
x
|
Nbr of stocks (in thousands)
|
60,212
|
60,487
|
60,633
|
60,816
|
58,044
|
58,308
|
-
|
-
|
Reference price
2 |
19.30
|
17.14
|
18.36
|
17.81
|
27.73
|
24.87
|
24.87
|
24.87
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,476
|
1,136
|
1,547
|
2,031
|
1,894
|
1,996
|
2,110
|
2,258
|
EBITDA
1 |
267.3
|
200
|
268
|
312.3
|
332.3
|
347
|
381.3
|
407.8
|
EBIT
1 |
170.6
|
103.5
|
163.9
|
206.6
|
219.3
|
223.1
|
253.9
|
285.8
|
Operating Margin
|
11.56%
|
9.11%
|
10.6%
|
10.17%
|
11.58%
|
11.17%
|
12.03%
|
12.66%
|
Earnings before Tax (EBT)
1 |
119.6
|
25.8
|
185.7
|
157.2
|
163.3
|
162.5
|
190.8
|
-
|
Net income
1 |
86.92
|
18.16
|
134.7
|
106.2
|
103.5
|
111.5
|
133.9
|
-
|
Net margin
|
5.89%
|
1.6%
|
8.71%
|
5.23%
|
5.46%
|
5.59%
|
6.35%
|
-
|
EPS
2 |
1.420
|
0.3000
|
2.210
|
1.730
|
1.730
|
1.880
|
2.250
|
-
|
Free Cash Flow
1 |
75.66
|
-19.66
|
-69.5
|
-152
|
173.1
|
27
|
46
|
58
|
FCF margin
|
5.12%
|
-1.73%
|
-4.49%
|
-7.48%
|
9.14%
|
1.35%
|
2.18%
|
2.57%
|
FCF Conversion (EBITDA)
|
28.3%
|
-
|
-
|
-
|
52.09%
|
7.78%
|
12.06%
|
14.22%
|
FCF Conversion (Net income)
|
87.04%
|
-
|
-
|
-
|
167.25%
|
24.22%
|
34.35%
|
-
|
Dividend per Share
2 |
0.8000
|
0.2000
|
0.0207
|
0.0800
|
-
|
0.0843
|
0.0946
|
0.1018
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
392.7
|
484.5
|
541.2
|
543.1
|
462.1
|
500.7
|
458.8
|
466.2
|
468.2
|
502.9
|
496.6
|
508.7
|
502.6
|
539.2
|
541.2
|
EBITDA
1 |
52.3
|
83.2
|
83.4
|
80.5
|
65.2
|
101.1
|
87
|
77.3
|
66.6
|
85.3
|
88.16
|
89.83
|
85.92
|
93.74
|
96.99
|
EBIT
1 |
22.8
|
55.9
|
56
|
55.3
|
39.4
|
75.4
|
59.8
|
49.4
|
34.4
|
56.4
|
56.08
|
58.08
|
52.52
|
61.13
|
64.28
|
Operating Margin
|
5.81%
|
11.54%
|
10.35%
|
10.18%
|
8.53%
|
15.06%
|
13.03%
|
10.6%
|
7.35%
|
11.21%
|
11.29%
|
11.42%
|
10.45%
|
11.34%
|
11.88%
|
Earnings before Tax (EBT)
1 |
4.1
|
46.2
|
-
|
43.4
|
25.2
|
60.5
|
47.7
|
35
|
20.1
|
40.1
|
40.7
|
45.6
|
36
|
50.1
|
51.6
|
Net income
1 |
1.1
|
32.5
|
-
|
31.8
|
12.2
|
42.3
|
30.1
|
26.2
|
4.9
|
26.7
|
28.2
|
31.6
|
25
|
35.2
|
36.2
|
Net margin
|
0.28%
|
6.71%
|
-
|
5.86%
|
2.64%
|
8.45%
|
6.56%
|
5.62%
|
1.05%
|
5.31%
|
5.68%
|
6.21%
|
4.97%
|
6.53%
|
6.69%
|
EPS
2 |
0.0100
|
0.5300
|
-
|
0.5200
|
0.2000
|
0.7000
|
0.5100
|
0.4400
|
0.0800
|
0.4500
|
0.4800
|
0.5300
|
0.4200
|
0.5900
|
0.6100
|
Dividend per Share
2 |
-
|
0.0207
|
0.0200
|
0.0200
|
0.0200
|
0.0200
|
0.0200
|
-
|
-
|
-
|
0.0203
|
0.0203
|
0.0203
|
0.0223
|
0.0223
|
Announcement Date
|
2/17/22
|
5/5/22
|
8/4/22
|
11/3/22
|
2/16/23
|
5/4/23
|
8/9/23
|
11/2/23
|
2/14/24
|
5/2/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
592
|
674
|
717
|
855
|
777
|
767
|
757
|
756
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.213
x
|
3.367
x
|
2.676
x
|
2.738
x
|
2.338
x
|
2.211
x
|
1.987
x
|
1.855
x
|
Free Cash Flow
1 |
75.7
|
-19.7
|
-69.5
|
-152
|
173
|
27
|
46
|
58
|
ROE (net income / shareholders' equity)
|
65.1%
|
34.1%
|
42%
|
27.3%
|
24.6%
|
24.7%
|
24.9%
|
24.2%
|
ROA (Net income/ Total Assets)
|
8.87%
|
4.73%
|
8.92%
|
6.03%
|
6.2%
|
6.55%
|
6.86%
|
7.1%
|
Assets
1 |
979.7
|
383.8
|
1,510
|
1,760
|
1,671
|
1,701
|
1,951
|
-
|
Book Value Per Share
2 |
3.090
|
2.990
|
5.270
|
7.580
|
8.260
|
9.350
|
11.00
|
12.30
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
156
|
145
|
215
|
233
|
173
|
195
|
185
|
163
|
Capex / Sales
|
10.56%
|
12.75%
|
13.88%
|
11.46%
|
9.12%
|
9.79%
|
8.77%
|
7.2%
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/14/24
|
-
|
-
|
-
|
Last Close Price
24.87
USD Average target price
29.83
USD Spread / Average Target +19.96% Consensus |
1st Jan change
|
Capi.
|
---|
| -10.31% | 1.45B | | +17.07% | 66.31B | | -0.29% | 48.46B | | +21.61% | 43.27B | | +26.72% | 27.41B | | +9.25% | 19.26B | | -2.14% | 16.61B | | +9.75% | 16.58B | | -15.01% | 14.41B | | -30.22% | 14.02B |
Other Specialty Chemicals
|